Literature DB >> 7140806

Pharmacokinetics of ticarcillin in man.

B E Davies, M J Humphrey, P F Langley, L Lees, B Legg, G A Wadds.   

Abstract

The excretion of radioactivity has been investigated in 3 healthy volunteers following rapid intravenous administration of 5 g of [35S]-ticarcillin. The radioactive dose was rapidly and completely excreted, since within 4 days 98.5% was recovered, 95% in the urine and 3.5% in faeces. All the urine radioactivity was accounted for as ticarcillin and its penicilloic acid. Plasma and urine samples collected from the volunteers at frequent intervals during the first 6 h of the experiment were assayed for penicillin by an automated chemical method and also for radioactivity. The results obtained by the chemical autoanalyser method were in excellent agreement with the plasma levels of radioactivity. From the data it was possible to calculate the renal clearance of the penicillin, a mean value of 104 ml/min was observed in the 3 volunteers. A further three volunteers were dosed intravenously with a 5 g bolus of non-radiolabelled ticarcillin in a cross-over study with and without predosing with probenecid. Serum samples were analysed by the chemical method for penicillin and the data subjected to pharmacokinetic analysis using a two compartment open model. The results indicate a shift of the distribution equilibrium of ticarcillin from the serum into the peripheral compartment after predosing with probenecid. Furthermore, the mean half-life of ticarcillin in the serum of the three volunteers was significantly increased from 1.3 h to 2.1 h by predosing with probenecid.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7140806     DOI: 10.1007/bf00545973

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  7 in total

1.  THE EFFECT OF PROBENECID IN DELAYING THE URINARY EXCRETIONS OF THE NEW PENICILLINS DERIVED FROM 6-AMINOPENICILLANIC ACID.

Authors:  O P ROBINSON
Journal:  Br J Clin Pract       Date:  1964-10

2.  COMPT, a time-sharing program for nonlinear regression analysis of compartmental models of drug distribution.

Authors:  M Pfeffer
Journal:  J Pharmacokinet Biopharm       Date:  1973-04

3.  Modification of penicillin distribution and elimination by probenecid.

Authors:  M Gibaldi; D Davidson; M E Plaut; M A Schwartz
Journal:  Int Z Klin Pharmakol Ther Toxikol       Date:  1970-05

4.  Ticarcillin vs carbenicillin: clinical pharmacokinetics.

Authors:  R D Libke; J T Clarke; E D Ralph; R P Luthy; W M Kirby
Journal:  Clin Pharmacol Ther       Date:  1975-04       Impact factor: 6.875

5.  -carboxy-3-thienylmethylpenicillin (BRL 2288), a new semisynthetic penicillin: absorption and excretion in man.

Authors:  R Sutherland; P J Wise
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

6.  -carboxy-3-thienylmethylpenicillin (BRL 2288), a new semisynthetic penicillin: in vitro evaluation.

Authors:  R Sutherland; J Burnett; G N Rolinson
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

7.  Metabolism of penicillins to penicilloic acids and 6-aminopenicillanic acid in man and its significance in assessing penicillin absorption.

Authors:  M Cole; M D Kenig; V A Hewitt
Journal:  Antimicrob Agents Chemother       Date:  1973-04       Impact factor: 5.191

  7 in total
  5 in total

Review 1.  Clinical pharmacology of antibiotics and other drugs in cystic fibrosis.

Authors:  J Prandota
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

2.  Pharmacokinetics of ticarcillin and clavulanic acid (timentin) in relation to renal function.

Authors:  G L Jungbluth; D L Cooper; G D Doyle; G M Chudzik; W J Jusko
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

Review 3.  Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance.

Authors:  R de Groot; A L Smith
Journal:  Clin Pharmacokinet       Date:  1987-10       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics of enzyme inhibitors in antimicrobial chemotherapy.

Authors:  I D Watson; M J Stewart; D J Platt
Journal:  Clin Pharmacokinet       Date:  1988-09       Impact factor: 6.447

5.  Studies of interaction of a low-molecular-weight heparinoid (Org 10172) with cloxacillin and ticarcillin in healthy male volunteers.

Authors:  A de Boer; J C Stiekema; M Danhof; T G van Dinther; J K Boeijinga; A F Cohen; D D Breimer
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.